GL1X · GenesisL1 explorer

MolNFT v1 · #74022 · protein

Alpha-keto-aldehyde binding mechanism reveals a novel lead structure motif for proteasome inhibition

3OKJ · Proteasome component Y7: “Alpha-keto-aldehyde binding mechanism reveals a novel lead structure motif for proteasome inhibition”. X-ray diffraction, 1 ligand (EP9), 20 pockets (best druggability 0.83). MolNFT v1 #74022 on GenesisL1…

PDB
3OKJ
Type
protein
Length
6,361 residues
Chains
28
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Proteasome component Y7; Proteasome component Y13; Proteasome component PRE6; Proteasome…
EC
3.4.25.1
UniProt
P23639, P23638, P40303, P32379, P40302, P21242, P21243, P25043, P25451, P22141, P30656, P23724, P30657, P38624
Ligands
EP9
Pockets
20 · best druggability 0.83

Structure

x-ray diffraction · 17 distinct chains · 34% helix, 28% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, OProteasome component Y7 (EC 3.4.25.1)protein25035% helix, 26% strandP23639
B, PProteasome component Y13 (EC 3.4.25.1)protein24437% helix, 25% strandP23638
C, QProteasome component PRE6 (EC 3.4.25.1)protein24137% helix, 23% strandP40303
D, RProteasome component PUP2 (EC 3.4.25.1)protein24237% helix, 26% strandP32379
E, SProteasome component PRE5 (EC 3.4.25.1)protein23336% helix, 27% strandP40302
F, TProteasome component C1 (EC 3.4.25.1)protein24438% helix, 25% strandP21242
G, UProteasome component C7-alpha (EC 3.4.25.1)protein24340% helix, 23% strandP21243
H, VProteasome component PUP1 (EC 3.4.25.1)protein22229% helix, 34% strandP25043
I, WProteasome component PUP3 (EC 3.4.25.1)protein20432% helix, 32% strandP25451
J, XProteasome component C11 (EC 3.4.25.1)protein19832% helix, 35% strandP22141
K, YProteasome component PRE2 (EC 3.4.25.1)protein21235% helix, 34% strandP30656
LProteasome component C5 (EC 3.4.25.1)protein22228% helix, 33% strandP23724
MProteasome component PRE4 (EC 3.4.25.1)protein23330% helix, 30% strandP30657
NProteasome component PRE3 (EC 3.4.25.1)protein19638% helix, 34% strandP38624
ZProteasome component C5 (EC 3.4.25.1)protein22126% helix, 25% strandP23724
1Proteasome component PRE4 (EC 3.4.25.1)protein22826% helix, 27% strandP30657
2Proteasome component PRE3 (EC 3.4.25.1)protein19528% helix, 26% strandP38624

Ligands and binding sites

  • EP9 · N-[(benzyloxy)carbonyl]-L-leucyl-N-[(2S,3S)-3-hydroxy-1-(4-hydroxyphenyl)-4-oxobutan-2-yl]-L-leucinamide · ligand · 2 copies · chains K, L, Y, Z

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

20 pockets found on a 1 Å grid, 20 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
19910.830.84140empty
29860.820.83113empty
39610.820.83102empty
48660.820.84120empty
511000.810.82102empty

Interfaces

92 interfaces between chains.

  • H–I · 1721 Ų buried · 27 hydrogen bonds · protein-protein
  • V–W · 1719 Ų buried · 27 hydrogen bonds · protein-protein
  • B–C · 1622 Ų buried · 29 hydrogen bonds · protein-protein
  • P–Q · 1590 Ų buried · 25 hydrogen bonds · protein-protein
  • L–V · 1479 Ų buried · 25 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 covalent (covalent ligand).

Compared structures

  • 3OKJ · Alpha-keto-aldehyde binding mechanism reveals a novel lead structure motif for proteasome… · the same entry in another collection · chain 1 against 1, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.